STAT News · Scour

Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77

statnews.com·2w

Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs

statnews.com·2w

STAT+: FDA to speed up review of 3 psychedelics as mental health treatments

statnews.com·2w

STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B

statnews.com·2w

STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment

statnews.com·2w

STAT+: Up and Down the Ladder: The latest comings and goings

statnews.com·2w

International childhood vaccine campaign grows

statnews.com·2w

STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more

statnews.com·2w

STAT+: Sanofi MS drug gets positive review in Europe following FDA

statnews.com·2w

Opinion: The local news crisis is also a public health crisis

statnews.com·2w

Psychedelics get a boost from the White House

statnews.com·2w

Growing use of guest editors has turned some journals into a ‘playground of bad science’

statnews.com·2w

Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learned

statnews.com·2w

A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts

statnews.com·3w

STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead

statnews.com·3w

Heart’s beat may help it beat cancer, mouse research suggests

statnews.com·3w

STAT+: Trump’s boosting of psychedelics, cannabis signals a new era in GOP drug policy

statnews.com·3w

STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boards

statnews.com·3w

Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at risk

statnews.com·3w

STAT+: Sanofi research priorities in flux as new CEO logs in

statnews.com·3w

Log in to enable infinite scrolling